4.7 Article

Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials

Vincent Wai-Sun Wong et al.

Summary: This study evaluated the performance of noninvasive tests in diagnosing advanced fibrosis due to NASH in white and Asian patients, and found that these tests performed similarly in both groups. However, the sensitivities of NFS, FIB-4, and ELF were low in white and Asian patients younger than 40 years.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Letter Gastroenterology & Hepatology

Diabetes Liver Fibrosis Score to Detect Advanced Fibrosis in Diabetics with Nonalcoholic Fatty Liver Disease

Amandeep Singh et al.

Summary: This study aims to develop a simple noninvasive fibrosis score to detect advanced fibrosis in patients with diabetes and compare its performance with other fibrosis scores.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population

Isabel Graupera et al.

Summary: This study found that FIB-4 and NFS have suboptimal accuracy for screening fibrosis in low-prevalence populations, with a high risk of overdiagnosis and a non-negligible percentage of false-negatives. Waist circumference emerges as a potential method for identifying individuals at risk for liver fibrosis in the general population.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Serum Fibrosis Tests Guide Prognosis in Metabolic Dysfunction-Associated Fatty Liver Disease Patients Referred From Primary Care

Zhengyi Wang et al.

Summary: The study found that noninvasive tests accurately stratify the risk of liver-related outcomes in patients with metabolic dysfunction-associated fatty liver disease (MAFLD) and can be used as a screening tool for patients referred by primary care.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Review Gastroenterology & Hepatology

2019 Global NAFLD Prevalence: A Systematic Review and Meta-analysis

Michael H. Le et al.

Summary: This study aimed to determine the global and regional prevalence trends of NAFLD. The results showed that the overall prevalence of NAFLD is increasing, despite regional variations. South America and North America have the highest prevalence rates. The study suggests that policy makers should increase awareness of NAFLD and promote healthy lifestyle environments to reverse this trend.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive Value

Fatima Higuera-de-la-Tijera et al.

Summary: The Hepamet Fibrosis Score (HFS) showed similar sensitivity and specificity for the diagnosis of advanced NAFLD as reported in the original publication, with a positive predictive value of 36.7% at a pretest probability of 14%. Further exploration of the role of HFS in prospective studies and in combination with other methods is warranted.

DIGESTIVE DISEASES AND SCIENCES (2021)

Article Gastroenterology & Hepatology

Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease

Ramy Younes et al.

Summary: This study compared various non-invasive scoring systems in identifying risk and predicting long-term outcomes for patients with non-alcoholic fatty liver disease. NFS, HFS, and FIB-4 outperformed APRI and BARD in both cross-sectional identification of fibrosis and prediction of long-term outcomes, making them useful tools for clinical management of NAFLD patients at increased risk of fibrosis and liver-related complications or death.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995-2040

Takanori Ito et al.

Summary: The prevalence of NAFLD in Japan is around 25.5%, with a higher incidence in males and a predicted increase to affect half of the population by 2040. Lean NAFLD individuals make up around 20% of the NAFLD population, with older age and higher mortality rates.

HEPATOLOGY INTERNATIONAL (2021)

Review Gastroenterology & Hepatology

Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

Emmanuel Anandraj Selvaraj et al.

Summary: Non-invasive tests measuring liver stiffness or using MRI have acceptable diagnostic accuracy for advanced fibrosis and cirrhosis. The potential clinical impact of these tests cannot be fully assessed due to lack of intention-to-diagnose analyses and validation of pre-specified thresholds.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update

Annalisa Berzigotti et al.

Summary: The article provides the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for assessing liver disease severity and prognosis, with a focus on topics with relevant evidence published in the last 5 years.

JOURNAL OF HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes

Hiroshi Ishiba et al.

Summary: In patients with or without diabetes who have NAFLD, COL4-7S may be the best NIT for identifying advanced fibrosis.

HEPATOLOGY COMMUNICATIONS (2021)

Letter Gastroenterology & Hepatology

Performance of Simple Fibrosis Scores in Nonobese Patients With Nonalcoholic Fatty Liver Disease

Charmaine Fu et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Review Radiology, Nuclear Medicine & Medical Imaging

Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement

Richard G. Barr et al.

RADIOLOGY (2020)

Article Gastroenterology & Hepatology

ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data Validation

Daniel Q. Huang et al.

HEPATOLOGY COMMUNICATIONS (2020)

Review Gastroenterology & Hepatology

Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers

Eduardo Vilar-Gomez et al.

JOURNAL OF HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

Stuart McPherson et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)

Article Gastroenterology & Hepatology

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Amy G. Shah et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)

Review Medicine, General & Internal

Current concepts: Liver biopsy.

AA Bravo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)